These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 7128189
1. Haemodynamic and haemorheological effects of buflomedil in patients with peripheral occlusive arterial disease. Perego MA, Sergio G, Espureo M, Francisci A, Artale F. Curr Med Res Opin; 1982; 8(3):178-87. PubMed ID: 7128189 [Abstract] [Full Text] [Related]
2. [Effect of the vasoactive drug buflomedil in arterial occlusive disease]. Racenberg J, Intaglietta M, Messmer K. Fortschr Med; 1982 Nov 04; 100(41):1926-30. PubMed ID: 7152426 [Abstract] [Full Text] [Related]
3. Haemorheological effects of fructose-1,6-diphosphate in patients with lower extremity ischaemia. Cacioli D, Clivati A, Pelosi P, Megevand J, Galeone M. Curr Med Res Opin; 1988 Nov 04; 10(10):668-74. PubMed ID: 3371082 [Abstract] [Full Text] [Related]
4. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients. Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T. J Int Med Res; 1984 Nov 04; 12(3):188-92. PubMed ID: 6734922 [No Abstract] [Full Text] [Related]
5. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation. Mozzi E, Chiurazzi D, Spinola A, Annoni F, Germiniani R. J Int Med Res; 1985 Nov 04; 13(6):317-21. PubMed ID: 4076530 [Abstract] [Full Text] [Related]
6. Protective effects of buflomedil against exercise-induced reductions in regional erythrocyte deformability of patients with peripheral arterial disease. Guerrini M, Acciavatti A, Materazzi M, Rossi C, Del Bigo C, Forconi S, Di Perri T. J Int Med Res; 1982 Nov 04; 10(6):387-93. PubMed ID: 7152076 [No Abstract] [Full Text] [Related]
7. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil]. Dorigo B, Raspanti D, Trapani M, Albanese B, Cameli AM, Digiesi V. Minerva Med; 1985 Feb 25; 76(7):269-75. PubMed ID: 3974940 [Abstract] [Full Text] [Related]
8. Effect of buflomedil chlorhydrate on local oxygen delivery in peripheral vascular disease. Mannarino E, Pasqualini L, Maragoni G, Orlandi U. Angiology; 1989 Jun 25; 40(6):559-62. PubMed ID: 2719340 [Abstract] [Full Text] [Related]
9. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation? Wysokinski WE, Spittell PC, Pellikka PA, Miller WL, Seward JB. Int Angiol; 1998 Sep 25; 17(3):201-7. PubMed ID: 9821035 [Abstract] [Full Text] [Related]
10. Buflomedil in arterial occlusive disease: results of a controlled multicenter study. Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W. Angiology; 1984 Aug 25; 35(8):500-5. PubMed ID: 6383127 [Abstract] [Full Text] [Related]
11. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease. Angelkort B, Maurin N, Boateng K. Curr Med Res Opin; 1979 Aug 25; 6(4):255-8. PubMed ID: 527350 [Abstract] [Full Text] [Related]
12. [Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin]. Ehrly AM. Med Welt; 1975 Mar 07; 26(10):446-55. PubMed ID: 1123988 [No Abstract] [Full Text] [Related]
13. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies]. Guerrini M, Pecchi S, Rossi C, Cappelli R, Pieragalli D, Acciavatti A. Ric Clin Lab; 1981 Mar 07; 11 Suppl 1():265-79. PubMed ID: 7188114 [No Abstract] [Full Text] [Related]
14. Blood flow properties and walking performance in chronic arterial occlusive disease. Angelkort B, Spürk P, Habbaba A, Mähder M. Angiology; 1985 May 07; 36(5):285-92. PubMed ID: 3896044 [Abstract] [Full Text] [Related]
15. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease. Ehrly AM. J Med; 1979 May 07; 10(5):331-8. PubMed ID: 294470 [No Abstract] [Full Text] [Related]
16. The influence of buflomedil on blood viscosity parameters in insulin-dependent diabetic patients: a preliminary study. Van Acker K, Rillaerts E, De Leeuw I. Biomed Pharmacother; 1989 May 07; 43(3):219-22. PubMed ID: 2775859 [Abstract] [Full Text] [Related]
17. [Effect of benfurodil hemiscucinate (Eucilat) on various hemorheologic parameters in patients with chronic peripheral obstructive arteriopathies]. Mozzi E, Annoni F, Chiurazzi D, Rossi R, Pacini F, Martini A. Minerva Cardioangiol; 1984 Mar 07; 32(3):141-9. PubMed ID: 6374499 [No Abstract] [Full Text] [Related]
18. [Hemorrheologic aspects in relation to the physiopathology and clinical aspects of peripheral occlusive arteriopathy]. Perego MA, Sergio G, Artale F. Ric Clin Lab; 1981 Mar 07; 11 Suppl 1():281-91. PubMed ID: 7188115 [No Abstract] [Full Text] [Related]
19. [Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies]. Sternitzky R, Hänsgen K, Podhaisky H. Z Gesamte Inn Med; 1991 Nov 07; 46(16):610-4. PubMed ID: 1792802 [Abstract] [Full Text] [Related]
20. [Clinical observations on the rheological and hemodynamic effects of some drugs acting on the microcirculation]. Motta G, Ratto GB. Minerva Med; 1980 May 12; 71(19):1367-76. PubMed ID: 6155647 [Abstract] [Full Text] [Related] Page: [Next] [New Search]